# The neuro-immune insights of itch: peripheral mechanisms and central glial contributions

## TL;DR

This review explains how itch is caused by interactions between the nervous system and immune responses, highlighting potential treatments.

## Contribution

The paper provides new insights into peripheral and central mechanisms of itch, emphasizing glial contributions and neuroimmune interactions.

## Key findings

- Peripheral itch is driven by pruriceptor activation via histamine, interleukins, and chemokines.
- Spinal glial cells amplify itch through cytokine release and pathways like STAT3 and TLR4.
- Understanding neuroimmune crosstalk could lead to better treatments for chronic itch conditions.

## Abstract

Itch is a common symptom of inflammatory, systemic, and neurological conditions and is often driven by persistent neuroinflammatory processes. This review explores the intricate mechanisms underlying itch, focusing on interactions among sensory neurons, immune mediators, and glial cells. Key peripheral pathways include activation of pruriceptors by histamine, interleukins, and chemokines, as well as inflammatory pathways dependent on Toll-like receptors (TLRs). These pathways promote the release of mediators such as interleukin-6 (IL-6) and C–C motif chemokine ligand 2 (CCL2). In the spinal cord, astrocytes and microglia contribute to itch amplification by releasing proinflammatory cytokines and activating signaling pathways such as signal transducer and activator of transcription 3 (STAT3) and TLR4. These processes drive central sensitization and facilitate the transition from acute to chronic itch in conditions such as atopic dermatitis, psoriasis, and allergic contact dermatitis. By summarizing advances in neuroimmune crosstalk and glial–neuronal interactions, this review identifies potential molecular targets for therapeutic strategies aimed at alleviating itch and improving patient outcomes.